GlassScriptPhysician profile
Mario Celaya
NPI 1124173786
$9,833.36
in general payments reported to CMS, 2019-2025
34 companies · $1,033 in 2025
The $1,033 reported for 2025 was more than what 84% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,553 · 2022: $1,809 · 2023: $1,931 · 2024: $2,506 · 2025: $1,033.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,386 · Education: $85.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,385.66 |
| Education | $85.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,889.59 | 2021-2025 | Breztri, Farxiga, Airsupra |
| Novo Nordisk INC | $1,436.74 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $1,131.52 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $1,127.72 | 2021-2025 | Repatha, Otezla, Tezspire |
| Corcept Therapeutics | $466.00 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $446.22 | 2021-2024 | Rexulti |
| Abbvie INC. | $441.34 | 2021-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $418.13 | 2021-2024 | Jardiance |
| Sunovion Pharmaceuticals INC. | $340.55 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $248.26 | 2023-2025 | Gemtesa |
| Merck Sharp & Dohme LLC | $247.07 | 2021-2024 | Verquvo, Belsomra, Steglatro |
| Mannkind Corporation | $237.10 | 2021-2025 | Afrezza |
| Idorsia Pharmaceuticals US INC | $171.63 | 2023 | Quviviq |
| Janssen Pharmaceuticals, INC | $160.17 | 2021 | |
| Novartis Pharmaceuticals Corporation | $146.50 | 2021-2023 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ani Pharmaceuticals, INC. | $131.09 | 2024-2025 | Purified Cortrophin Gel |
| Bayer Healthcare Pharmaceuticals INC. | $129.85 | 2023-2025 | |
| Phathom Pharmaceuticals, INC. | $129.71 | 2024-2025 | Voquezna |
| Antares Pharma, INC. | $53.89 | 2025 | Xyosted |
| Baxter Healthcare | $42.58 | 2023-2024 | Hillrom - Life 2000 Ventilation System, Hillrom - Monarch Airway Clearance System |
| Amarin Pharma, INC. | $41.30 | 2021 | |
| Glaxosmithkline, LLC. | $39.60 | 2021-2023 | Pediarix, Bexsero, Rotarix |
| Axsome Therapeutics, INC. | $37.60 | 2023 | Auvelity |
| Eisai INC. | $36.49 | 2021 | |
| Agile Therapeutics, INC. | $36.40 | 2024 | Twirla |
| Pfizer INC. | $36.31 | 2023-2024 | |
| Cranial Technologies, INC | $34.05 | 2023-2025 | Doc Band |
| Exact Sciences Corporation | $33.31 | 2024-2025 | Cologuard Collection Kit |
| Ironwood Pharmaceuticals, INC | $33.23 | 2023-2024 | Linzess |
| Sanofi-Aventis U.S. LLC | $28.92 | 2021 | |
| Mylan Specialty L.P. | $27.44 | 2021-2022 | |
| Ultragenyx Pharmaceutical INC. | $20.48 | 2024 | Crysvita |
| Dexcom, INC. | $17.05 | 2025 | Dexcom G6 Transmitter |
| Alkermes, INC. | $15.52 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mario Celaya listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.